-

Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of CURO Group Holdings, Corp. (CURO)

SAN DIEGO & WICHITA, Kan.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that it is investigating the officers and directors of CURO Group Holdings, Corp. (NYSE: CURO) for breaches of fiduciary duties, unjust enrichment, and violations of the Securities Exchange Act of 1934. CURO is a diversified consumer finance company, provides consumer finance to a range of underbanked consumers.

If you suffered a loss as a result of CURO's misconduct, click here.

CURO Group Holdings, Corp. (CURO) Sued for Misleading Shareholders About FY 2018 Guidance

Shareholders filed a securities fraud class action against CURO, alleging that between April 27, 2018 and October 24, 2018, defendants materially misrepresented to investors the negative effect that the rapid transition from payday loans to open-end loans, along with other changes, was having on the company's financial performance and 2018 full-year company guidance. The false statements caused CURO stock to trade at artificially inflated prices – as high as $31 per share. However, as the truth of the wrongdoing was revealed the stock plummeted to $15.18 per share.

CURO challenged these allegations and on December 3, 2019, U.S. District Court Judge John W. Lungstrum denied CURO's motion to dismiss plaintiffs' claims, stating that the facts supported the notion that CURO's executives "were at least reckless in failing to disclose that the decision to accelerate the transition would call into question the accuracy of the 2018 guidance." The Court’s denial of CURO's motion to dismiss could result in substantial financial damage to CURO as litigation proceeds.

CURO Group Holdings, Corp. (CURO) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against CURO settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Franklin BSP Realty Trust, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Franklin BSP Realty Trust, Inc. (NYSE: FBRT) securities between November 5, 2024 and February 11, 2026. FBRT is a real estate investment trust that "originates, acquires and manages a diversified portfolio of commercial real estate debt secured by properties located in the United States." For more information, submit a form, email attorney Aar...

Investor Notice: Robbins LLP Informs Investors of the Snowflake Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Investor Notice: Robbins LLP Informs Investors of the Class Action Lawsuit on Behalf of Zynex, Inc. Stockholders

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Zynex, Inc. (NASDAQ: ZYKIQ) securities between February 25, 2021 and December 15, 2025. Zynex is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis, and cardiac monitoring. For more information, submit a form, email attorney Aaron Dumas, Jr....
Back to Newsroom